Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man

Published:2003-10-22 Issue:5 Volume:56 Page:505-512
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Downham M. R.,Auton T. R.,Rosul A.,Sharp H. L.,Sjöström L.,Rushton A.,Richards J. P.,Mant T. G. K.,Gardiner S. M.,Bennett T.,Glover J. F.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2003.01926.x/fullpdf

Reference42 articles.

1. Angiotensin-converting enzyme inhibitors;Brown;Circulation,1998

2. Angiotensin II receptor inhibition;Messerli;Arch Intern Med,1996

3. Non-angiotensin effects of angiotensin-converting enzyme inhibitors;Sunman;Clin Sci,1993

4. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system;Horiuchi;Hypertension,1999

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Landscape of Therapeutics for the Management of Hypertension - A Review;Current Drug Delivery;2024-06

2. Targeting aging and age-related diseases with vaccines;Nature Aging;2024-04-15

3. Immunization, Vaccines, and Immunomodulation;Early Vascular Aging (EVA);2024

4. Future treatments in hypertension: Can we meet the unmet needs of patients?;European Journal of Internal Medicine;2023-09

5. Two decades of vaccine development against atherosclerosis;Nano Today;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP